Details for New Drug Application (NDA): 012097
✉ Email this page to a colleague
NDA 012097 describes KENALOG IN ORABASE, which is a drug marketed by Delcor Asset Corp and is included in one NDA. Additional details are available on the KENALOG IN ORABASE profile page.
The generic ingredient in KENALOG IN ORABASE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
The generic ingredient in KENALOG IN ORABASE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 012097
| Tradename: | KENALOG IN ORABASE |
| Applicant: | Delcor Asset Corp |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012097
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | PASTE;DENTAL | Strength | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
